Carisma Therapeutics
Entity

  • Carisma Therapeutics

    Created in 2016
  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    403 12,746

  • Activities

    biotech deeptech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    3675 Market St #401, Philadelphia, PA 19104, USA

    Philadelphia

    United States of America

  • Employees

    Scale: 51-200

    Estimated: 99

  • Engaged corporates

    4
    1 3

  • Added in Motherbase

    2 years, 5 months ago
Description
  • Value proposition

    Pioneering CAR Macrophage Immunotherapy to Target Solid Tumors

    Carisma Therapeutics is a clinical stage biopharmaceutical company developing a differentiated and proprietary cell therapy platform focused on engineered macrophages to transform the treatment of cancer and other serious illness.

  • Carisma | CAR-Macrophages | Innovative Immunotherapy

    Carisma is pioneering the development of CAR-Macrophages and CAR-Monocytes, disruptive approaches to solid tumor immunotherapy treatment.

    • https://carismatx.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Nasdaq
Nasdaq
Finance, Financial Services
Nasdaq
Finance, Financial Services 		Other

29 Mar 2023


Moderna
Moderna
Pharmaceutical, Biotechnology, Biotechnology Research
Moderna
Pharmaceutical, Biotechnology, Biotechnology Research 		Other

14 Dec 2023


EY
EY
Consulting, audit, IT Services and IT Consulting
EY
Consulting, audit, IT Services and IT Consulting 		Other

31 May 2022


IP Group plc
IP Group plc
Financial Services
IP Group plc
Financial Services 		Other

21 Oct 2021


Similar entities
Last news
Show all articles
Social network dynamics